Amelivu

E2041315 UNEXPLORED

Amelivu is a biosimilar medication developed by Samsung Bioepis, likely used in the treatment of autoimmune or inflammatory diseases.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
Amelivu canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Samsung Bioepis → hasProduct → Amelivu ⓘ